Application 018753
- Type
- NDA
- Sponsor
- INTL MEDICATION
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FUROSEMIDE | FUROSEMIDE | TABLET;ORAL | 20MG | No | No |
| 002 | FUROSEMIDE | FUROSEMIDE | TABLET;ORAL | 40MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018753-001 | FUROSEMIDE | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | ||
| N018753-002 | FUROSEMIDE | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Furosemide | FUROSEMIDE | Leading Pharma, LLC | b5c6fcf4-fd37-4fee-8dac-1a3273d95ffe | 2022-11-11 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Precision Dose Inc. | 4a746634-379b-4847-a965-7607d2a71bed | 2022-09-21 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Aphena Pharma Solutions - Tennessee, LLC | 6f124d7d-a19d-4de6-8ea4-719a42eb520b | 2022-03-10 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | c5d9b063-e3fe-ec2f-e053-2995a90ab3f2 | 2021-06-28 | Warnings, Adverse reactions | FUROSEMIDE FUROSEMIDE |
| Furosemide | FUROSEMIDE | Proficient Rx LP | ce84359c-2f76-421a-9b2b-79b1c2be2f20 | 2021-01-01 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Gland Pharma Limited | 644704c0-e6a5-4804-bfa6-795c8f83aa7a | 2020-07-03 | Boxed warning, Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Aphena Pharma Solutions - Tennessee, LLC | 1d2733ac-6fa6-44d1-96d4-f1a698045ad2 | 2018-04-18 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Aphena Pharma Solutions - Tennessee, LLC | 6fbf7f3d-7566-44d5-9507-c4460238fc91 | 2018-02-09 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.